Medifron Dbt Co., Ltd.

Calculating rank

USPTO Granted Patents = 4

% Expired Patents = 75.0

EPO Patents = 1

Trademarks = 3

Forward Citations = 0

Loading Chart...

7 inventors (with patents filed for the assignee):

Eun Joo Nam (4 out of 6 patents)

Hee Sun Kim (4 out of 22 patents)

Chan Mi Joung (4 out of 15 patents)

4. Hee Jin Ha (4 out of 4 patents)

5. Young Ho Kim (4 out of 22 patents)

6. Dong Wook Kang (4 out of 21 patents)

7. Jee Woo Lee (4 out of 9 patents)

4 patents: Sort by Forward Citations

1. 8580848 - Benzofuran type derivatives, a composition comprising the same for treating or preventing cognitive dysfunction and the use thereof (2013-11-12),

2. 8507553 - Benzofuran type derivatives, a composition comprising the same for treating or preventing cognitive dysfunction and the use thereof (2013-08-13),

3. 8455542 - Benzofuran type derivatives, a composition comprising the same for treating or preventing cognitive dysfunction and the use thereof (2013-06-04),

4. 8263649 - Benzofuran type derivatives, a composition comprising the same for treating or preventing cognitive dysfunction and the use thereof (2012-09-11),

Company Overview

Medifron Dbt Co., Ltd. is a leading medical device company specializing in providing cutting-edge technology and solutions for diabetes management. With a focus on innovation and quality, we offer a wide range of products and services to help improve the lives of people living with diabetes. Our dedicated team of experts is committed to delivering personalized care and support to our customers, making us a trusted partner in diabetes care.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

4 Patents

#767 in Seoul

#2,203 in South Korea

Seoul, South Korea

Medifron Dbt Co., Ltd.

Forward Citations = 0

7 inventors:

Eun Joo Nam (4 out of 6 patents)

Hee Sun Kim (4 out of 22 patents)

Chan Mi Joung (4 out of 15 patents)

4. Hee Jin Ha (4 out of 4 patents)

5. Young Ho Kim (4 out of 22 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Medifron Dbt Co., Ltd.. Retrieved from https://idiyas.com/company/medifron-dbt-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]